OnDemand
SGLT2 Inhibition Spotlight - exploring benefits across diabetes, kidney disease, and heart failure
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Faculty
  • Agenda
  • Program Materials
  • Funding Support
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES and a PROGRAM WORKSHEET. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

program advertising tile
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES and a PROGRAM WORKSHEET. View the Program Materials tab for more information.

Credits:
This program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

program advertising tile

Description:

A case-based discussion on SGLT2 inhibition across the spectrum of diabetes, kidney disease, and heart failure.

Following participation in this program, participants will be able to:

  1. Review the protection provided SGLT2 inhibitors along the clinical spectrum of diabetes and cardiorenal disease.
  2. Identify the role of earlier SGLT2 inhibition treatment in the at-risk patient with diabetes.
  3. Explore the potential for SGLT2 inhibitors to exert clinical benefits beyond diabetes in the management of heart failure.

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

Milan Gupta
MD, FRCPC, FCCS, CPC(HC)
Brampton, ON
Sue Pederson
MD, FRCPC
Calgary, AB
Andrew Steele
MD, FRCPC
Oshawa, ON
Program Chapter
Presenter
SGLT2 inhibitors across the diabetes and cardio-renal spectrum
Milan Gupta
The patient with high-risk diabetes
Sue Pederson
The patient with chronic kidney disease
Andrew Steele
The patient with heart failure
Milan Gupta
Practical management tips around SGLT2 inhibitor use
All

Download program handout/worksheet: 

Participant Handout

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.

Access CCRN Member Resource Library.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from Astra Zeneca Canada.

© 2020-2021 MDLearn, All Rights are Reserved